Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Grace PM, Loram LC, Christianson JP, Strand KA, Flyer-Adams JG, Penzkover KR, Forsayeth JR, van Dam AM, Mahoney MJ, Maier SF, Chavez RA, Watkins LR.

Brain Behav Immun. 2017 Jan;59:49-54. doi: 10.1016/j.bbi.2016.05.012. Epub 2016 May 14.

2.

Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts.

Chen PY, Ozawa T, Drummond DC, Kalra A, Fitzgerald JB, Kirpotin DB, Wei KC, Butowski N, Prados MD, Berger MS, Forsayeth JR, Bankiewicz K, James CD.

Neuro Oncol. 2013 Feb;15(2):189-97. doi: 10.1093/neuonc/nos305. Epub 2012 Dec 21.

3.

AAV9: over the fence and into the woods . . .

Forsayeth JR, Bankiewicz KS.

Mol Ther. 2011 Jun;19(6):1006-7. doi: 10.1038/mt.2011.95. No abstract available.

4.

Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.

Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS, Starr PA, Martin AJ, Lonser RR, Federoff HJ, Forsayeth JR, Bankiewicz KS.

Mol Ther. 2011 Jun;19(6):1048-57. doi: 10.1038/mt.2011.11. Epub 2011 Feb 22.

5.

Future applications: gene therapy.

Richardson RM, Varenika V, Forsayeth JR, Bankiewicz KS.

Neurosurg Clin N Am. 2009 Apr;20(2):205-10. doi: 10.1016/j.nec.2009.04.004. Review.

6.

Engineering GPCR signaling pathways with RASSLs.

Conklin BR, Hsiao EC, Claeysen S, Dumuis A, Srinivasan S, Forsayeth JR, Guettier JM, Chang WC, Pei Y, McCarthy KD, Nissenson RA, Wess J, Bockaert J, Roth BL.

Nat Methods. 2008 Aug;5(8):673-8. doi: 10.1038/nmeth.1232. Review.

7.

Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.

Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS.

Neurotherapeutics. 2008 Jan;5(1):123-7. doi: 10.1016/j.nurt.2007.10.064. Review.

8.

A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.

Forsayeth JR, Eberling JL, Sanftner LM, Zhen Z, Pivirotto P, Bringas J, Cunningham J, Bankiewicz KS.

Mol Ther. 2006 Oct;14(4):571-7. Epub 2006 Jun 16.

9.

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.

Bankiewicz KS, Daadi M, Pivirotto P, Bringas J, Sanftner L, Cunningham J, Forsayeth JR, Eberling JL.

Exp Neurol. 2006 Feb;197(2):363-72. Epub 2005 Dec 9.

10.

Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats.

Sanftner LM, Rivera VM, Suzuki BM, Feng L, Berk L, Zhou S, Forsayeth JR, Clackson T, Cunningham J.

Mol Ther. 2006 Jan;13(1):167-74. Epub 2005 Aug 26.

11.

AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.

Sanftner LM, Sommer JM, Suzuki BM, Smith PH, Vijay S, Vargas JA, Forsayeth JR, Cunningham J, Bankiewicz KS, Kao H, Bernal J, Pierce GF, Johnson KW.

Exp Neurol. 2005 Aug;194(2):476-83.

12.

Systemic administration of propentofylline does not attenuate morphine tolerance in non-injured rodents.

Shumilla JA, Samuels I, Johnson KW, Forsayeth JR.

Neurosci Lett. 2005 Aug 26;384(3):344-8.

PMID:
15953678
13.

Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.

Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR.

Eur J Neurosci. 2005 Apr;21(8):2136-48.

PMID:
15869510
14.
15.

Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10.

Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R, Watkins LR.

Mol Pain. 2005 Feb 25;1:9.

16.

Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV.

Sanftner LM, Suzuki BM, Doroudchi MM, Feng L, McClelland A, Forsayeth JR, Cunningham J.

Mol Ther. 2004 Mar;9(3):403-9.

17.

Acetylcholine receptors are required for agrin-induced clustering of postsynaptic proteins.

Marangi PA, Forsayeth JR, Mittaud P, Erb-Vögtli S, Blake DJ, Moransard M, Sander A, Fuhrer C.

EMBO J. 2001 Dec 17;20(24):7060-73.

18.

Pharmacological differences between immunoisolated native brain and heterologously expressed rat alpha4beta2 nicotinic receptors.

Truong A, Xing X, Forsayeth JR, Dwoskin LP, Crooks PA, Cohen BN.

Brain Res Mol Brain Res. 2001 Nov 30;96(1-2):68-76.

PMID:
11731010
19.

UNCL, the mammalian homologue of UNC-50, is an inner nuclear membrane RNA-binding protein.

Fitzgerald J, Kennedy D, Viseshakul N, Cohen BN, Mattick J, Bateman JF, Forsayeth JR.

Brain Res. 2000 Sep 15;877(1):110-23.

PMID:
10980252
20.

Volatile anesthetics activate the human tandem pore domain baseline K+ channel KCNK5.

Gray AT, Zhao BB, Kindler CH, Winegar BD, Mazurek MJ, Xu J, Chavez RA, Forsayeth JR, Yost CS.

Anesthesiology. 2000 Jun;92(6):1722-30.

PMID:
10839924
21.

Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.

Shafaee N, Houng M, Truong A, Viseshakul N, Figl A, Sandhu S, Forsayeth JR, Dwoskin LP, Crooks PA, Cohen BN.

Br J Pharmacol. 1999 Nov;128(6):1291-9.

22.

TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family.

Chavez RA, Gray AT, Zhao BB, Kindler CH, Mazurek MJ, Mehta Y, Forsayeth JR, Yost CS.

J Biol Chem. 1999 Mar 19;274(12):7887-92. Erratum in: J Biol Chem 1999 Aug 20;274(34):24440.

23.

TOK1 is a volatile anesthetic stimulated K+ channel.

Gray AT, Winegar BD, Leonoudakis DJ, Forsayeth JR, Yost CS.

Anesthesiology. 1998 Apr;88(4):1076-84.

PMID:
9579518
24.

An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum.

Leonoudakis D, Gray AT, Winegar BD, Kindler CH, Harada M, Taylor DM, Chavez RA, Forsayeth JR, Yost CS.

J Neurosci. 1998 Feb 1;18(3):868-77.

25.

Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism.

Eilers H, Schaeffer E, Bickler PE, Forsayeth JR.

Mol Pharmacol. 1997 Dec;52(6):1105-12.

PMID:
9415721
26.

Detection of mycoplasma infection of mammalian cells.

Xia H, Fitzgerald J, Bredt DS, Forsayeth JR.

Biotechniques. 1997 May;22(5):934-6.

27.
28.

A recombinant adenovirus that directs secretion of biologically active kappa-bungarotoxin from mammalian cells.

Gorman S, Viseshakul N, Cohen B, Hardy S, Grant GA, Yost CS, Forsayeth JR.

Brain Res Mol Brain Res. 1997 Feb;44(1):143-6.

PMID:
9030709
29.

Volatile general anesthetics produce hyperpolarization of Aplysia neurons by activation of a discrete population of baseline potassium channels.

Winegar BD, Owen DF, Yost CS, Forsayeth JR, Mayeri E.

Anesthesiology. 1996 Oct;85(4):889-900.

PMID:
8873561
30.

Intraluminal water increases expression of plasmid DNA in rat lung.

Sawa T, Miyazaki H, Pittet JF, Widdicombe JH, Gropper MA, Hashimoto S, Conrad DJ, Folkesson HG, Debs R, Forsayeth JR, Fox B, Wiener-Kronish JP.

Hum Gene Ther. 1996 May 20;7(8):933-41.

PMID:
8727507
31.

Adenovirus-mediated transfection of cultured cells.

Forsayeth JR, Garcia PD.

Biotechniques. 1994 Aug;17(2):354-6, 357-8.

PMID:
7980940
33.

Assembly of the mammalian muscle acetylcholine receptor in transfected COS cells.

Gu Y, Forsayeth JR, Verrall S, Yu XM, Hall ZW.

J Cell Biol. 1991 Aug;114(4):799-807.

34.

Expression of functional mouse muscle acetylcholine receptors in Chinese hamster ovary cells.

Forsayeth JR, Franco A Jr, Rossi AB, Lansman JB, Hall ZW.

J Neurosci. 1990 Aug;10(8):2771-9.

35.

Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells.

Gu Y, Franco A Jr, Gardner PD, Lansman JB, Forsayeth JR, Hall ZW.

Neuron. 1990 Aug;5(2):147-57.

PMID:
2383398
36.

Clusters of 43-kDa protein are absent from genetic variants of C2 muscle cells with reduced acetylcholine receptor expression.

LaRochelle WJ, Ralston E, Forsayeth JR, Froehner SC, Hall ZW.

Dev Biol. 1989 Mar;132(1):130-8.

PMID:
2645181
37.

Reversal of insulin-induced negative cooperativity by monoclonal antibodies that stabilize the slowly dissociating ("Ksuper") state of the insulin receptor.

Gu JL, Goldfine ID, Forsayeth JR, De Meyts P.

Biochem Biophys Res Commun. 1988 Jan 29;150(2):694-701.

PMID:
3277631
38.

Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity.

Forsayeth JR, Caro JF, Sinha MK, Maddux BA, Goldfine ID.

Proc Natl Acad Sci U S A. 1987 May;84(10):3448-51.

39.

Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation.

Forsayeth JR, Montemurro A, Maddux BA, DePirro R, Goldfine ID.

J Biol Chem. 1987 Mar 25;262(9):4134-40.

40.

Inhibition of insulin-stimulated xylose uptake in rat soleus muscle by cycloheximide.

Forsayeth JR, Gould MK.

Diabetologia. 1983 Nov;25(5):429-32.

PMID:
6360781
41.

Supplemental Content

Loading ...
Support Center